Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Unknown 5Terminated 4Completed 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Prostatic Intraepithelial Neoplasia 2Precancerous Conditions 1Osteoporosis 1Neoplasms, Hormone-Dependent 1Neoplasms 1Fractures, Bone 1Desmoid Tumors 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Bone Diseases, Metabolic 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Toremifene × Clear all
NCT02344940 2019-09-24

TTOS

Shanghai Jiao Tong University School of Medicine

Phase 4 Completed
104 enrolled
Breast

Breast Neoplasms

NCT00044291 2015-07-31

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Intarcia Therapeutics

Phase 3 Completed
865 enrolled
Breast

Breast Neoplasms, Neoplasms, Hormone-Dependent, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00002529 2013-04-04

12-93

ETOP IBCSG Partners Foundation

Phase 3 Completed
452 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡